PLUS THERAPEUTICS, Inc. Common Stock

PSTVNASDAQUSD
3.33 USD
0.23 (6.46%)AT CLOSE (11:59 AM EDT)
3.33
0.06 (1.80%)
POST MARKET (AS OF 04:44 PM EDT)
Post Market
AS OF 04:44 PM EDT
3.33
0.06 (1.80%)
🟢Market: OPEN
Open?$3.50
High?$3.84
Low?$3.25
Prev. Close?$3.56
Volume?534.5K
Avg. Volume?5.4M
VWAP?$3.45
Rel. Volume?0.10x
Bid / Ask
Bid?$2.86 × 100
Ask?$3.93 × 100
Spread?$1.07
Midpoint?$3.40
Valuation & Ratios
Market Cap?24.4M
Shares Out?N/A
Float?125.4M
Float %?90.3%
P/E Ratio?N/A
P/B Ratio?6.11
EPS?-$3.84
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.87Weak
Quick Ratio?0.87Weak
Cash Ratio?0.35Low
Debt/Equity?0.19Low
ValuationFAIRLY VALUED
Score
75/100
P/E?
N/A
P/B?
6.11FAIR
P/S?
4.69FAIR
P/FCF?
N/A
EV/EBITDA?
-1.4CHEAP
EV/Sales?
4.01FAIR
Returns & Efficiency
ROE?
-659.3%WEAK
ROA?
-161.4%WEAK
Cash Flow & Enterprise
FCF?$-20842000
Enterprise Value?$20.9M
Related Companies
Loading...
News
Profile
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Employees
28
Market Cap
24.4M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2000-11-16
Address
4200 MARATHON BLVD.
AUSTIN, TX 78756
Phone: 737.255.7194